Ironwood Investment Management LLC Immuno Gen, Inc. Transaction History

Ironwood Investment Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$12.46 - $29.95 $1,320 - $3,174	-106 Reduced 0.06%	174,540 $5.18 Million
Q3 2023 Nov 16, 2023	SELL	$14.09 - $19.87 $273,825 - $386,153	-19,434 Reduced 10.01%	174,646 $2.77 Million
Q2 2023 Aug 11, 2023	BUY	$3.75 - $20.05 $1,226 - $6,556	327 Added 0.17%	194,080 $3.66 Million
Q1 2023 May 15, 2023	SELL	$3.67 - $4.92 $18,643 - $24,993	-5,080 Reduced 2.55%	193,753 $744,000
Q4 2022 Jan 31, 2023	BUY	$4.55 - $6.31 $96,610 - $133,980	21,233 Added 11.96%	198,833 $986,000
Q3 2022 Nov 14, 2022	SELL	$4.48 - $6.47 $474 - $685	-106 Reduced 0.06%	177,600 $849,000
Q2 2022 Aug 12, 2022	BUY	$3.15 - $5.76 $456 - $835	145 Added 0.08%	177,706 $800,000
Q1 2022 May 10, 2022	BUY	$4.26 - $7.48 $756,409 - $1.33 Million	177,561 New	177,561 $845,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Ironwood Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ironwood Investment Management LLC with notifications on news.